Riskpilot← Back to searchSign inGet full accessVentri Labs AB
ABActiveOrg 5594633439Entreprenörsstråket 10Manufacture of fluid power equipment · NACE 2812Est. 20231 employees
Revenue 2025
SEK 0
EBITDA margin
—
+45% vs 2024
Equity ratio
92.3%
Financial strength
Net profit 2025
SEK -211K
+44% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -225K | +45% |
| Net profit | SEK -211K | +44% |
| Total assets | SEK 7,7M | +59% |
| Equity | SEK 7,1M | +127% |
| Employees | 1 | — |
Legal name
Ventri Labs AB
Org number
5594633439
Legal form
Aktiebolag
NACE code
2812 · Manufacture of fluid power equipment
Founded
15 december 2023
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva verksamhet inom utveckling, marknadsföring och försäljning av flödesteknisk apparatur för biotekniska och medicintekniska applikationer samt därmed förenlig verksamhet.
Address
Entreprenörsstråket 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | — | 0 |
| Staff expenses | −89 | −8 |
| EBITDA | −410 | −225 |
| Depreciation & amort. | — | — |
| EBIT | −410 | −225 |
| Net financials | 32 | 15 |
| Profit before tax | −378 | −211 |
| Tax | — | — |
| Net profit | −378 | −211 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 4 871 | 7 747 |
| Equity | 3 147 | 7 150 |
| Long-term debt | — | — |
| Short-term debt | 1 724 | 597 |
| Total debt | 1 724 | 597 |
EBITDA margin
-22531600.0%
This company
15.8%
Market median
-142605163% vs market
20242025
Equity ratio
92.3%
This company
38.2%
Market median
+142% vs market
20242025
Return on equity
-2.9%
This company
18.4%
Market median
-116% vs market
20242025
Net profit margin
-21056800.0%
This company
8.1%
Market median
-259960594% vs market
20242025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20242025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RÖ Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2023 | |
| Board of Directors | 2025 | |
| Chairman | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Biotech Fluidics AB
Ventri Labs AB Board members of Ventri Labs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Robin Öz | Chief Executive Officer | 0 companies |
| Ulf Lars-Olof Andersson | Board of Directors | 0 companies |
| John Fritiof Pontén | Board of Directors | 0 companies |
| Annica Elisabeth Grimberg Lignell | Board of Directors | 0 companies |
| Gustaf Axel Einar Pontén | Chairman | 0 companies |